Simon E Moroney

Title: Simon E Moroney: Innovator in Blocked Lectins

Introduction

Simon E Moroney is a distinguished inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of methods and materials related to lectins. With a total of 2 patents, Moroney's work has the potential to impact medical treatments and research.

Latest Patents

Moroney's latest patents focus on "Blocked lectins; methods and affinity support for making the same." These patents describe an activated affinity ligand that includes a region with affinity for binding sites of a lectin and a reactive group capable of covalently linking the ligand to the lectin. This innovation allows for the blocking of one or more binding sites of the lectin. Additionally, the patents detail a cell-binding agent-blocked lectin conjugate, which comprises the blocked lectin and a cell-binding agent linked to either the affinity ligands or the lectin itself. The methods outlined in these patents also include techniques for preparing the conjugate and the affinity support capable of binding to a lectin.

Career Highlights

Simon E Moroney is currently associated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research and innovations. His work is pivotal in the development of targeted therapies that utilize lectins for selective cell targeting.

Collaborations

Some of Moroney's notable coworkers include Walter A Blattler and John M Lambert. Their collaborative efforts contribute to the ongoing research and development in the field of lectin-based therapies.

Conclusion

Simon E Moroney's innovative work in the area of blocked lectins showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment methodologies and enhancing our understanding of cellular interactions.